Literature DB >> 8862425

HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.

M D Schwartz1, R J Geraghty, A T Panganiban.   

Abstract

Vpu and the C-terminal peptide of Gag (p6) are both HIV-1-encoded proteins that augment the release of virus particles from cells. We examined the functional relationship between these proteins and their activities during particle release. Our results indicate that efficient HIV-1 particle release from HeLa and Jurkat cells depends on the presence of Vpu. However, Vpu is dispensable for efficient release from Cos cells. In contrast, p6 is required for efficient release from Cos cells but not from Jurkat or HeLa cells. These data suggest that Vpu and p6 have distinct activities in virus exit from different cell lines. Intracellular proteolytic processing of Gag precursor protein is more complete in Cos cells than in HeLa cells. However, this processing has little or no effect on Vpu- or p6-mediated particle release. p6 is required for incorporation of yet another virus protein (Vpr) into cells but our data suggest that Vpr plays no role in p6-dependent particle release. Vpu also facilitates the degradation of CD4 in virus producing cells but, in contrast to particle release, the ability of Vpu to facilitate the degradation of CD4 is not cell line-dependent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862425     DOI: 10.1006/viro.1996.0532

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.

Authors:  N Srinivasakumar; F G Schuening
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.

Authors:  C Chen; F Li; R C Montelaro
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.

Authors:  Beth Noble; Paolo Abada; Juan Nunez-Iglesias; Paula M Cannon
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.

Authors:  Y M Lee; B Liu; X F Yu
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.

Authors:  Feng Li; Chaoping Chen; Bridget A Puffer; Ronald C Montelaro
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.

Authors:  Paolo Abada; Beth Noble; Paula M Cannon
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.

Authors:  M Dettenhofer; X F Yu
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.

Authors:  Satoshi Komoto; Shoutaro Tsuji; Madiha S Ibrahim; Yong-Gang Li; Jiranan Warachit; Koki Taniguchi; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.

Authors:  Mohammed S Ali; Jason Hammonds; Lingmei Ding; Paul Spearman
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

10.  Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.

Authors:  Vasundhara Varthakavi; Ellen Heimann-Nichols; Rita M Smith; Yuehui Sun; Richard J Bram; Showkat Ali; Jeremy Rose; Lingmei Ding; Paul Spearman
Journal:  Nat Med       Date:  2008-05-25       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.